The OhioHealth Research Institute (OHRI) fosters the delivery of better medical treatments, the application of more effective technology and the enhancement of our patients’ personal experiences through clinical trials, innovations and other programs.
We actively participate in regional, national and international research clinical trials and networks.
Under the leadership of Gary Ansel, MD, principal Investigator, OhioHealth was named a Top 2018 enroller to the National Institutes of Health-funded study, Crest 2. The OhioHealth Research Institute's work contributed greatly to the national enrollment, helping our patients get the very best care for their carotid disease.
Steven J. Yakubov, MD, co-authored a publication in the New England Journal of Medicine for OHRI participation in a research study titled "Transcatheter Aortic-Valve Replacement With a Self-Expanding Valve in Low-Risk Patients." This study reflects continuing advancement in the treatment of valvular heart disease. This article reveals that newer heart valves may let patients avoid surgery in the future. Read the journal article.
Nirav Vora, MD, was recently published in Stroke related to OHRI participation in the national study entitled "Impact of Balloon Guide Catheter Use on Clinical and Angiographic Outcomes in the STRATIS Stroke Thrombectomy Registry." The outcome suggests that routine use of balloon guide catheter (BCG) may improve rates of early revascularization success and good clinical outcomes. Read the article.
Our commitment to exceptional care means finding all avenues to help our patients receive the best and most advanced clinical treatment available.Find a Clinical Trial
We view clinical research as an extension of clinical care because it allows our physicians, nurses and other clinicians to provide leading-edge treatments to patients.Learn More